Nurix Therapeutics (NRIX) Cash from Operations (QoQ) (2020 - 2026)
Powered by 
Analysis
Nurix Therapeutics (NRIX) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.42 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -34.29% |
| Feb 28, 2026 | -6.02% |
| Nov 30, 2025 | -18.21% |
| Aug 31, 2025 | 9.14% |
| May 31, 2025 | -3.40% |
| Feb 28, 2025 | -25.30% |
| Nov 30, 2024 | -15.59% |
| Aug 31, 2024 | -6.23% |
| May 31, 2024 | 5.35% |
| Feb 29, 2024 | -257.18% |
| Nov 30, 2023 | 164.88% |
| Aug 31, 2023 | -122.71% |
| May 31, 2023 | 61.88% |
| Feb 28, 2023 | -27.66% |
| Nov 30, 2022 | 18.04% |
| Aug 31, 2022 | -40.69% |
| May 31, 2022 | 22.79% |
| Feb 28, 2022 | -37.91% |
| Nov 30, 2021 | -3.13% |
| Aug 31, 2021 | 4.96% |